Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Newspaper Article
|
Hoechst Marion Roussel Commits $1.5 Million to Aetna's Quality Care Research Fund for Outcomes ResearchPR newswire, 1997-11-20, p.1120COPYRIGHT 1997 PR Newswire Association LLCDigital Resources/Online E-Resources |
|
2 |
Material Type: Newspaper Article
|
Hoechst Marion Roussel Commits $1.5 Million to Aetna's Quality Care Research Fund for Outcomes ResearchPR newswire, 1997-11-20, p.1120COPYRIGHT 1997 PR Newswire Association LLCDigital Resources/Online E-Resources |
|
3 |
Material Type: Newspaper Article
|
Hoechst Marion Roussel Commits $1.5 Million to Aetna's Quality Care Research Fund for Outcomes ResearchPR newswire, 1997-11-20, p.1120COPYRIGHT 1997 PR Newswire Association LLCDigital Resources/Online E-Resources |
|
4 |
Material Type: Newspaper Article
|
Onyx Pharmaceuticals Announces Exercise of Over-Allotment Option for Public OfferingPR newswire, 2000-10-21, p.3868-3868COPYRIGHT 2000 PR Newswire Association LLC ;COPYRIGHT 2000 PR Newswire Association LLCDigital Resources/Online E-Resources |
|
5 |
Material Type: Newspaper Article
|
Entremed, Inc. Announces Commencement of Phase I Clinical Trial Of Angiostatin Protein in Combination With Radiation TherapyPR newswire, 2000-07-06, p.3471-3471COPYRIGHT 2000 PR Newswire Association LLC ;COPYRIGHT 2000 PR Newswire Association LLCDigital Resources/Online E-Resources |
|
6 |
Material Type: Newspaper Article
|
Onyx Announces New Members of Board of DirectorsPR newswire, 2000-06-13COPYRIGHT 2000 PR Newswire Association LLC ;COPYRIGHT 2000 PR Newswire Association LLCDigital Resources/Online E-Resources |
|
7 |
Material Type: Newspaper Article
|
CI-1042 (ONYX-015) May Have Potential Against Cancer in Variety of Tumor TypesPR newswire, 2000-05-24, p.6013-6013COPYRIGHT 2000 PR Newswire Association LLC ;COPYRIGHT 2000 PR Newswire Association LLCDigital Resources/Online E-Resources |
|
8 |
Material Type: Newspaper Article
|
Onyx Pharmaceuticals Announces $18 Million Private Placement, New Management AppointmentsPR newswire, 2000-01-19, p.4569-4569COPYRIGHT 2000 PR Newswire Association LLCDigital Resources/Online E-Resources |
|
9 |
Material Type: Newspaper Article
|
FDA Agrees With Onyx's Phase III Trial Design for Onyx-015 In Head and Neck CancerPR newswire, 1999-09-07, p.1806COPYRIGHT 1999 PR Newswire Association LLCDigital Resources/Online E-Resources |
|
10 |
Material Type: Newspaper Article
|
FDA Agrees With Onyx's Phase III Trial Design for Onyx-015 In Head and Neck CancerPR newswire, 1999-09-07, p.1806COPYRIGHT 1999 PR Newswire Association LLCDigital Resources/Online E-Resources |
|
11 |
Material Type: Newspaper Article
|
FDA Agrees With Onyx's Phase III Trial Design for Onyx-015 In Head and Neck CancerPR newswire, 1999-09-07, p.1806COPYRIGHT 1999 PR Newswire Association LLCDigital Resources/Online E-Resources |
|
12 |
Material Type: Newspaper Article
|
Warner Chilcott Management Increases Stake in CompanyPR newswire, 1999-01-08, p.0838COPYRIGHT 1999 PR Newswire Association LLCDigital Resources/Online E-Resources |
|
13 |
Material Type: Newspaper Article
|
Warner Chilcott Management Increases Stake in CompanyPR newswire, 1999-01-08, p.0838COPYRIGHT 1999 PR Newswire Association LLCDigital Resources/Online E-Resources |
|
14 |
Material Type: Newspaper Article
|
Warner Chilcott Management Increases Stake in CompanyPR newswire, 1999-01-08, p.0838COPYRIGHT 1999 PR Newswire Association LLCDigital Resources/Online E-Resources |
|
15 |
Material Type: Newspaper Article
|
Affymetrix Announces Definitive Agreement to Sell $50 Million of Series AA Preferred StockPR newswire, 1998-03-10, p.310COPYRIGHT 1998 PR Newswire Association LLCDigital Resources/Online E-Resources |
|
16 |
Material Type: Newspaper Article
|
Affymetrix Announces Definitive Agreement to Sell $50 Million of Series AA Preferred StockPR newswire, 1998-03-10, p.310COPYRIGHT 1998 PR Newswire Association LLCDigital Resources/Online E-Resources |
|
17 |
Material Type: Newspaper Article
|
Affymetrix Announces Definitive Agreement to Sell $50 Million of Series AA Preferred StockPR newswire, 1998-03-10, p.310COPYRIGHT 1998 PR Newswire Association LLCDigital Resources/Online E-Resources |
|
18 |
Material Type: Newspaper Article
|
Immunicon Announces Agreement With Ortho-Clinical Diagnostics, Inc.; Companies to Collaborate on Screening and Diagnostic Products for CancerPR newswire, 2000-09-11COPYRIGHT 2000 PR Newswire Association LLC ;COPYRIGHT 2000 PR Newswire Association LLCDigital Resources/Online E-Resources |
|
19 |
Material Type: Newspaper Article
|
Leonard E. Post, Former Parke-Davis V.P. Biologicals, Joins Onyx Pharmaceuticals as Senior Vice President, Research DevelopmentPR newswire, 2000-08-03COPYRIGHT 2000 PR Newswire Association LLC ;COPYRIGHT 2000 PR Newswire Association LLCDigital Resources/Online E-Resources |
|
20 |
Material Type: Newspaper Article
|
New Agreements Provide Onyx With Novel Technology and Genes for Developing A Range of Anticancer TherapiesPR newswire, 2000-08-02COPYRIGHT 2000 PR Newswire Association LLC ;COPYRIGHT 2000 PR Newswire Association LLCDigital Resources/Online E-Resources |